NICE Says Vertex Must ‘Engage Fully’ In UK Orkambi Negotiations

 
• By Ian Schofield

Health technology assessment body NICE says Vertex must engage “fully” with the institute so that it can complete its evaluations of the company’s CF drugs.

Tortoise
Progress is still slow in UK talks on Orkambi • Source: Shutterstock

More from United Kingdom

More from Europe